The Financial Impact of Post-Acute Care in Medicare Advantage

Thursday, April 19th, 2018 | 11:00am PT / 2:00pm ET

A recording of the webinar will be available soon!

Many Medicare Advantage plans are beginning to recognize the need to reduce costs associated with post-acute care, particularly to optimize their Medicare bids – but most don’t have the expertise to identify the best areas for potential cost reduction. This is unfortunate, as post-acute care accounts for up to 25 percent of a Medicare Advantage plan’s total spend.

Every post-acute care journey is characterized by transitions – from hospital to a Skilled Nursing Facility (SNF), or to an Inpatient Rehabilitation Facility (IRF), or to recovery at home. At each transition, the path splits, but providers may have incomplete information at the point a decision is needed. Often, Medicare Advantage plans do not have the specialized resources to manage the complexity of the post-acute care continuum. This results in increased risk for adverse patient outcomes, waste, and additional costs.

Participants will learn how to:

  • Identify the 3 key areas that can drive down post-acute care costs and lower Medicare bids
  • Choose the right metrics for cost-savings analyses and benchmarks for comparison
  • Understand the roles that Home Health and DME play in reducing readmissions



Dr. Karen Johnston

Medical Director, CareCentrix

Trained as an internist at UCSF, Dr. Karen Johnston is currently Medical Director at CareCentrix. She started her career as a partner in a 50-physician multi-specialty group practice. She subsequently shifted to positions as medical director and chief medical officer at cardiovascular prevention programs ranging from academic to commercial to venture-capital backed startups. Most recently, she co-founded a self-funded start-up, eMedBracelet, an electronic personal health record. She has a passion for global health and serves on the board of Bridges to Community, a non-governmental organization working in Nicaragua and the Dominican Republic.

Marcus Lanznar

VP Market Development and Strategy, CareCentrix

Marcus Lanznar is VP of Market Development and Strategy at CareCentrix, the leader in post-acute management. He is responsible for product strategy and growth initiatives at CareCentrix. Marcus also has significant experience as a consultant in the healthcare space across pharm, biotech and healthcare services.